Although SCG2 and CALB2 were downregulated in patients with CRC in multiple cohorts, qPCR experiments showed that their expression was upregulated in several CRC cell lines (such as HCT116 and HT29). The gene discussed is SCG2; the disease is colorectal carcinoma.